The Patent Finder

Satiogen Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Satiogen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 2 of 2 · Back to Satiogen Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 10,555,950Bile acid recycling inhibitors for treatment of obesity and diabetes
Lapsed on the fee record
Ended Feb 11, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 11, 2024From the USPTO record
US 8,366,650Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases
Lapsed on the fee record
Ended Feb 5, 2021 · From the USPTO record
Lapsed on the fee recordEnded Feb 5, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited